D.C. Mun. Regs. tit. 22, r. 22-B7399
When used in this chapter, the following terms have the meanings ascribed:
Affected property - a residence where a child with an elevated blood lead level resides or regularly visits and which is a likely source of the lead contributing to the elevated blood lead level.
Blood lead level or BLL - the concentration of lead in a sample of whole blood expressed in micrograms per deciliter ([MICRO]/dL).
Case management - the interdisciplinary treatment and care of a child with an elevated blood lead level, consisting of coordinated medical, social, and environmental services. This term includes diagnostic testing and medical evaluation for complications of lead poisoning; pharmacological treatment, if appropriate; follow-up testing at appropriate intervals; family lead education, housekeeping, and nutritional intervention; appropriate referrals, including referral to the Childhood Lead Poisoning Prevention Program and referral for child development and social services; environmental investigation and assessment; and the elimination or reduction of lead hazards, including source control measures necessary to eliminate or control any lead-based paint hazard to which a lead-poisoned child is exposed.
Child - a person under six (6) years of age.
Childhood Lead Poisoning Prevention Program or Program - the office in the Department of Health or a successor program or agency responsible for receiving reports and results concerning a child's blood lead level.
Department - the Department of Health.
Diagnostic test - the first venous blood level test performed within six (6) months on a child with a previously elevated blood level of lead on a screening test. A test performed more than six (6) months after the original screening test is a new screening test, with decisions about further testing and treatment based on the new screening test.
Elevated blood lead level - the concentration of lead in a sample of whole blood equal to or greater than ten (10) micrograms of lead per deciliter ([MICRO]/dL).
Follow-up test - a venous blood lead level test used to monitor the status of a child with a prior diagnostic test indicating an elevated blood lead level.
Health care facility - a facility providing individual care or treatment of diseases or other medical, physiological, or psychological conditions, including hospitals, clinics, laboratories, nursing homes, or homes for the aged or chronically ill, but excluding private medical offices.
Health care provider - a physician, clinic, hospital, or neighborhood health center, licensed by the District of Columbia, that is responsible for providing primary care and coordinating referrals, when necessary, to other health care providers.
Lead-based paint activities - that term as used in § 2(9) of the Lead-Based Paint Abatement and Control Act of 1996, effective April 9, 1997 (D.C. Law 11-221; D.C. Official Code § 8-115.01(9) ).
Lead-poisoned child - a child with a confirmed blood lead level equal to or greater than fifteen (15) micrograms per deciliter ([MICRO]/dL), or any other lower threshold that the United States Centers for Disease Control and Prevention may establish in written guidance or regulation.
Lead hazard - any source or pathway that results, or that may result, in exposure to lead, including lead-based paint; lead-contaminated dust or soil; sources related to occupations or work sites of parents, guardians, and caregivers (take-home exposure); airborne lead; and lead in water, food, ceramics, traditional remedies, cosmetics, and materials used in hobbies and other home activities.
Owner - a person who, alone or jointly or severally with others, meets either of the following criteria:
Person - an individual, corporation, partnership, firm, conservator, receiver, trustee, executor, or legal representative.
Screening test - a laboratory test for lead poisoning that is performed on a blood sample from an asymptomatic child to determine the child's blood lead level.
D.C. Mun. Regs. tit. 22, r. 22-B7399